Protected by a healthy indoor air quality
The CONQUAIR project (ICT Applications to CONquer Optimal Quality of AIR in Long-Term Care Settings) is an ambitious initiative designed to transform air quality management in healthcare environments. Launched in September 2024 and supported by ‘Eureka-Eurostars,’ this innovative two-year collaboration brings together EMBIO Diagnostics (coordinator), the University of Florence, Class Srl (Italy), and Resysten Kft (Hungary). CONQUAIR’s primary goal is to develop cutting-edge Information and Communication Technology (ICT) solutions that ensure optimal air quality in long-term care facilities, addressing a critical health challenge while aligning with the strategic RIS3 agenda.
Indoor air pollution, a major global health concern, contributes to 2.7% of all illnesses worldwide, as highlighted by the World Health Organization. Shockingly, 92% of the global population lives in areas where pollutant levels exceed WHO recommendations. Healthcare facilities are particularly vulnerable, serving as both hotspots and sources of airborne pathogens. These pathogens, spread through suboptimal Indoor Air Quality (IAQ), often result from inadequate ventilation, insufficient hygiene, and the absence of advanced monitoring systems. The consequences are significant: vulnerable patients—such as the immunocompromised, elderly, and children—are at greater risk of contracting serious infections, leading to widespread health-associated infections (HAIs).
Every year, over 3.2 million patients across the European Union contract infections in healthcare settings, with 37,000 lives lost directly to these infections. Beyond the human cost, HAIs place a massive financial burden on healthcare systems, with direct medical expenses ranging from $34 to $74 billion annually, and social costs adding an additional $62 to $73 billion.
The COVID-19 pandemic has heightened awareness of the importance of IAQ and infection control, making projects like CONQUAIR more essential than ever. By introducing advanced air quality monitoring and prevention systems, CONQUAIR is not only protecting healthcare facilities but also extending its impact to hospices, offices, schools, and other communal spaces. This project promises to set new standards in air quality management, helping to safeguard health and enhance well-being across multiple environments.
hospitals involved
Bank of Cyprus Oncology Center
Located in Nicosia, the Bank of Cyprus Oncology Center specializes in the diagnosis and treatment of cancer. Established through a collaboration between the Bank of Cyprus and local healthcare institutions, it provides integrated, personalized care with a strong focus on research, prevention, and psychological support for patients and their families
Careggi
Careggi University Hospital is one of the main healthcare and research centers in Florence and the wider Tuscany region. It hosts multiple medical specialties, state-of-the-art departments, and plays a key role in academic training. The hospital delivers high-quality care as well as diagnostic and therapeutic services within a broad network of national and international collaborations.
Nikosia General Hospital
Nikosia General Hospital is the largest and most advanced hospital in Cyprus, providing specialized and comprehensive healthcare as the country’s only quaternary care center.
St. Rafael Hospital
St. Rafael Hospital, located in Zala Coynty, Hungary, offers comprehensive healthcare through 11 central departments dedicated to diagnosis, therapy, and patient care.
Devices
airbeld™ Eos with its powerful sensors and proprietary algorithm, provides real-time understanding of indoor pollutants and helps take informed decisions to sustain a
healthy and comfortable environment.
airbeld™ system is an integrated, cost-effective monitoring system designed to assess Indoor Air Quality (IAQ) and promptly detect and report hazardous incidents that directly impact health and
well-being.
airbeld™ gives us a real-time understanding of indoor pollutants and thus helps us make decisions to maintain a healthy and comfortable environment.
Resysten® hygiene coating technology binds at a molecular level to any surface creating unhabitable conditions for biological contaminants to survive.
Antiviral – Proven to kill (GLP lab tested) SARs CoV1, SARs CoV2, Ebola, HBV, etc.
Anti-microbial Provent to kill (GLP lab tested) hospital superbugs, MRSA, etc. Anti-fungi, Anti-mold Anti-odor.
The Resysten® Clean Air coating actively breaks down airborne pollutants, reducing the concentration of harmful compounds and allergens, thereby contributing to cleaner and healthier
indoor air.
Our Partners
